checkAd

    Celyad Oncology SA  133  0 Kommentare Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLC - Seite 2

    6,500,000

    0

    0

    0.00 %

    0.00 %

    CFIP CLYD (UK) Limited

    0

    7,954,808

    0

    27.53%

    0.00 %

    Subtotal

    6,500,000

    7,954,808

     

    27.53%

     

     

    TOTAL

    7,954,808

    0

    27.53%

    0.00 %

    B) Equivalent financial instruments

    After the transaction

    Holders of equivalent
    financial instruments

    Type of financial
    instrument

    Expiration date

    Exercise period
    or date

    # of voting rights
    that may be
    acquired if the
    instrument is
    exercised

    % of voting
    rights

    Settlement

     

     

     

     

    0

    0.00%

     

     

    TOTAL

     

    0

    0.00%

     

    TOTAL (A & B)

     

    # of voting rights

    % of voting rights

    CALCULATE

    7,954,808

    27.53%

    • Full chain of controlled undertakings through which the holdings is effectively held:
      • CFIP CLYD (UK) Limited (“CFIP UK”), a United Kingdom limited liability company and a wholly- owned subsidiary of CFIP, directly holds 7,954,808 Ordinary Shares.
      • CFIP CLYD LLC, a Delaware limited liability company (“CFIP”), is the parent of CFIP UK.
      • FIP II UB Investments LP, a Delaware limited partnership (“FIP II”), holds 50% of the membership interests in CFIP.
      • FIP Fund II GP LLC, a Delaware limited liability company (“FIP II GP”), is the general partner of FIP II.
      • Hybrid GP Holdings LLC, a Delaware limited liability company (“Hybrid GP”), is the parent of FIP II GP and indirectly controls the general partners of certain investment funds that hold membership interests in CFIP.
      • FIG LLC, a Delaware limited liability company (“FIG LLC”), indirectly controls the investment advisers to certain investment funds that hold membership interests in CFIP.
      • Fortress Operating Entity I LP, a Delaware limited partnership (“FOE I”), is (i) the sole owner of FIG LLC and (ii) the managing member of, and holds the majority of equity interest in, Hybrid GP.
      • FIG Corp., a Delaware corporation (“FIG Corp.”), is the general partner of FOE I.
      • Fortress Investment Group LLC, a Delaware limited liability company (“Fortress”), is the sole owner of FIG Corp and has no controlling shareholder.
    • Additional information:

    This transparency notification covers the following transactions:

    Seite 2 von 4



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Celyad Oncology SA Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLC - Seite 2 Regulatory News: Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major …